Prevalence of anti HCV, HBsAg and HIV antibodies in high risk recipients of blood and blood products.
Indian J Public Health
;
2006 Jan-Mar; 50(1): 43-4
Artigo
em Inglês
| IMSEAR
| ID: sea-109820
ABSTRACT
Along with hepatitis B virus (HBV) and human immunodeficiency virus (HIV), Hepatitis C virus (HCV) is emerging as a major transfusion hazard. 22 cases of haemophilia (A 19, B 3) and 20 cases of thalassaemia (2 16, E(2) 4) constituted the study group. Patients tested for anti HCV (using third generation ELISA), HBsAg and antibodies to HIV I and II. Prevalence of anti HCV was 54.5% in haemophilics and 5% in thalassaemics. HBsAg was detected in 9.09% haemophilics and 5% thalassaemics. No anti HIV was detected in this cohort. Anti HCV seropositivity in haemophilics has increased compare to previous studies.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Talassemia
/
Transfusão de Sangue
/
Humanos
/
Estudos Soroepidemiológicos
/
Criança
/
Pré-Escolar
/
Prevalência
/
Adolescente
/
HIV
/
Hepatite C
Tipo de estudo:
Estudo de etiologia
/
Estudo de prevalência
/
Fatores de risco
Idioma:
Inglês
Revista:
Indian J Public Health
Ano de publicação:
2006
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS